Effects of the New Antiarrhythmic Peptide ZP123 on Epicardial Activation and Repolarization Pattern

Cell Communication and Adhesion

Volumn 10, Issue 42100, 2003, Pages 371-378

  Dhein, Stefan ^a   Larsen, Bjarne D ^b   Petersen, J⊘rgen S ^b   Mohr, Friedrich Wilhelm ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Zealand Pharma AS   (Denmark)

Author keywords

Antiarrhythmic peptide; arrhythmia; gap junctions; heart; PKC

Indexed keywords

AAP 10; ACETYL DEXTRO TYROSYL DEXTRO PROLYL DEXTRO HYDROXYPROLYLGLYCYL DEXTRO GLYCYLAMIDE; ANTIARRHYTHMIC PEPTIDE; GLYCYLALANYLGLYCYL 4 HYDROPROLYLPROLYLTYROSYLAMIDE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; ROTIGAPTIDE; SERUM ALBUMIN; SILVER CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CELL CULTURE; CLINICAL PROTOCOL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG PULSE THERAPY; ELECTROCARDIOGRAPHY; ELECTRODE; ENZYME ACTIVATION; ENZYME STABILITY; HEART CONTRACTION; HEART LEFT VENTRICLE PERFORMANCE; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART RATE; HEART RATE VARIABILITY; HEART REPOLARIZATION; HELA CELL; IN VITRO STUDY; ISOLATED HEART; MALE; NONHUMAN; PRESSURE; PRIORITY JOURNAL; TISSUE PERFUSION;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; CONNEXIN 43; ELECTROCARDIOGRAPHY; ENZYME INHIBITORS; GAP JUNCTIONS; HEART; HEART CONDUCTION SYSTEM; HELA CELLS; HUMANS; MALE; MYOCARDIAL CONTRACTION; OLIGOPEPTIDES; PROTEIN DENATURATION; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; RABBITS; RATS;

ANIMALIA; BOVINAE; ORYCTOLAGUS CUNICULUS;

EID: 0347126467     PISSN: 15419061     EISSN: 15435180     Source Type: Journal    
DOI: 10.1080/cac.10.4-6.371.378     Document Type: Article

References (18)

1. Dhein S, Krüsemann K, Schaefer T (1999). Effects of the gap junction uncoupler palmitoleic acid on the activation and repolarization wavefronts in isolated rabbit hearts. Br J Pharmacol 128: 1375–1384.
2. Dhein S, Tudyka T (1995). Therapeutic potential of antiarrhythmic peptides. Cellular coupling as a new antiarrhythmic target. Drugs 49: 851–855.
3. Dhein S, Manicone N, Müller A, Gerwin R, Ziskoven U, Irankhahi A, Minke C, Klaus W (1994). A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia. A mapping study. Naunyn Schmiedeberg's Arch Pharmacol 350: 174–184.
4. Müller A, Schaefer T, Gottwald M, Tudyka T, Linke W, Klaus W, Dhein S (1997). Effect of the antiarrhythmic peptide AAP10 on cellular coupling. Naunyn Schmiedeberg's Arch Pharmacol 356: 76–82.
5. Weng S, Lauven M, Schaefer T, Polontchouk L, Grover R, Dhein S (2002). Pharmacological modulation of Gap Junction coupling by an antiarrhythmic peptide via protein kinase C activation. FASEB J 16: 1114–1116.
6. Dhein S, Weng S, Grover R, Tudyka T, Gottwald M, Schaefer T, Polontchouk L (2001). Protein kinase C? mediates the effect of antiarrhythmic peptide on gap junction conductance. Cell Commun Adhesion 8: 257–264.
7. Grover R, Dhein S (2001). Structure-activity relationships of novel peptides related to the antiarrhythmic peptide AAP10 which reduce the dispersion of epicardial action potential duration. Peptides 22: 1011–1021.
8. Kjølbye AL, Knudsen CB, Jepsen T, Larsen BD, Petersen JS (2003). Pharmacological characterization of the new stable antiarrhythmic peptide analogue ZP123: In vivo and in vitro studies. J Pharmacol Exp Ther 306: 1191–1199.
9. Xing D, Kjolbye AL, Nielsen MS, Petersen JS, Harlow KW, Holstein-Rathlou N-H, Martins JB (2003). ZP123 increases gap junctional conductance and prevents reentrant ventricular tachycardia during myocardial ischemia in open chest dogs. J Cardiovasc Electrophysiol 14: 510–520.
10. Dhein S, Müller A, Gerwin R, Klaus W (1993). Comparative study on the proarrhythmic effects of some antiarrhythmic agents. Circulation 87: 617–630.
11. Lesh MD, Pring M, Spear JF (1989). Cellular uncoupling can unmask dispersion of action potential duration in ventricular myocardium. Circ Res 65: 1426–1440.
12. Kuo CS, Munakata K, Reddy CP, Surawicz B (1983). Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation 67: 1356–1367.
13. Arisi G, Macchi E, Baruffi S, Spaggiari S, Taccardi B (1983). Potential field on the ventricular surface of the exposed dog heart during normal excitation. Circ Res 52: 706–715.
14. Wit AL, Dillon SM. (1993). Anisotropic reentry. In Cardiac Mapping. Shenasa M, Borggrefe M, Breithardt G, eds., pp. 127–154. Futura Publishing Company, Mount Kisco, NY.
15. Hofmann J (1997). The potential for isoenzyme-selective modulation of PKC. FASEB J 11: 649–669.
16. Buchanan JW, Saito T, Gettes LS (1985). The effects of antiarrhythmic drugs, stimulation frequency and potassium-induced resting membrane potential changes on conduction velocity and dV/dtmax in guinea pig myocardium. Circ Res 56: 696–703.
17. Joyner RW (1982). Effects of the discrete pattern of electrical coupling on propagation through an electrical syncytium. Circ Res 50: 192–200.
18. Weingart R, Maurer P (1988). Action potential transfer in cell pairs from adult rat and guinea pig ventricles. Circ Res 63: 72–80.